Clinical trial · Observational
Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer
Evaluation of the Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer
NCT02740491CI-TRIAL-00101554REVIScompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main objective of this study is to describe the evolution in quality of life (QLQ-C30) for patients receiving breast cancer care at 3, 6 and 12 months after a "remission" consultation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Remission Consultation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- The study population
- description
- The study population consists of adult patients diagnosed with localized breast cancer who have completed adjuvant treatment (chemotherapy, radiotherapy) and who are cared for in the Medical Oncology department of the Nîmes University Hospital.
- interventionNames
- Other: Remission Consultation
Primary outcomes (4)
- measure
- The EORTC QLQ-C30 questionnaire
- timeFrame
- Day 0
- measure
- The EORTC QLQ-C30 questionnaire
- timeFrame
- Month 3
- measure
- The EORTC QLQ-C30 questionnaire
- timeFrame
- Month 6
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * The patient is receiving care for localized breast cancer and finished her adjuvant treatment (chemotherapy, radiotherapy) * The patient has completed his/her adjuvant therapy in the last 6 months (chemotherapy, radiotherapy). Exclusion Criteria: * The patient is participating in another study * The patient is under judicial protection * It is impossible to correctly inform the patient * The patient has a metastatic form of the disease at diagnosis
References
Publications (1)
- RESULTAlonso S, Kabani S, Fabbro-Peray P, Houede N, Duwig L. A feasibility study of scheduling a remission consultation in the management of patients treated for localized breast cancer. BMC Psychol. 2025 Sep 29;13(1):1087. doi: 10.1186/s40359-025-03393-6. PMID 41024190